Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2016

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

A summary of the status of our stock options as of September 30, 2016, and changes during the nine-month period then ended, is presented below:

	Nine Months Ended September 30, 2016
	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life	Aggregate Intrinsic Value
Outstanding at beginning of period		5,437,064		$	1.96
Granted		459,457			1.05
Exercised		—			—
Canceled and Forfeited		(1,900,790	)		1.66
Expired		(299,000	)		2.42
Outstanding at end of period		3,696,731		$	1.97	6.7 years	$	90,039
Exercisable at end of period		2,602,167		$	2.04	6.2 years	$	88,815

Schedule of Nonvested Restricted Stock Activity

A summary of the status of our unvested restricted stock as of September 30, 2016, and changes during the nine-month period then ended, is presented below:

	Nine Months Ended September 30, 2016
	Number of Shares			Weighted Average Grant-Date Fair Value
Unvested at beginning of period		361,000		$	1.69
Granted		168,000			1.20
Vested		(66,000	)		1.65
Forfeited		(206,000	)		1.77
Unvested at end of period		257,000		$	1.32